Patient Education and Guidance on Lorlatinib and Other ALK Inhibitors

Opinion
Video

Key opinion leaders focus on educating patients about potential side effects of lorlatinib and other ALK inhibitors, including guidance on when to contact their care team.

Video content above is prompted by the following:

  • How do you educate patients on potential side effects of lorlatinib and other ALK inhibitors?
  • What guidance do you provide about when to reach out to their care team?
Recent Videos
Photo of Jamie Carroll, APRN, CNP, MSN, from a video call with an Oncology Nursing News branded border around the frame
5 experts in this video
Image of Kayle Freeman, DNP, APRN, FNP-C, in a video call with an Oncology Nursing News border around the frame
Image of Jessie Desir, PhD, RN, AMB-BC, OCN, in a video call with a blue and gold Oncology Nursing News border surrounding the frame.
Image of Pattie Jakel, MN, RN, AOCN, in front of a blue watercolor Oncology Nursing News backdrop
Related Content